This study aims to verify the therapeutic efficacy and safety of a traditional Chinese medicine, Jingling Oral Liquid, in treating ADHD through a multicenter, randomized, double-blind, placebo-controlled trial (ChiCTR-IPR-17012293).
Method:
Eighty-five children with ADHD underwent 8 weeks of strictly monitored treatment. Forty children (8.2 ± 2.1 years old, nine girls) were randomly assigned to be treated with Jingling Oral Liquid (Liaoning Dongfangren Pharmaceutical Co., Ltd.), and 41 children (8.6 ± 2.5 years old, six girls) received placebo treatment.
Results:
Significant improvement was observed in the total score of ADHD rating scale (−4.8, 95% CI [−8.4, −1.1], p = .011) and in the hyperactivity/impulsivity score (−3.0, 95% CI [−4.8, −1.1], p = 0.002) for the Medicine group compared with the Placebo group, but not for inattention score (−1.9, 95% CI [−4.0, 0.2], p = 0.078). No significant changes were observed in the physiological indicators of the children pre- and post-treatment, and no definite drug-related adverse reactions were reported.
Conclusion:
Jingling Oral Liquid has shown efficacy in managing ADHD, specifically targeting hyperactivity and impulsivity symptoms, and maintaining a favorable safety profile.
AlessandriniE.BrakoF.ScarpaM.LupoM.BonifaziD.PignataroV.CavalloM.CullufeO.EnacheC.NafriaB.ClaverolJ.De TaeyeL.VermeulenE.PrestonJ.TuleuC. (2021). Children’s preferences for oral dosage forms and their involvement in formulation research via EPTRI (European Paediatric Translational Research Infrastructure). Pharmaceutics, 13(5), 730. https://doi.org/10.3390/pharmaceutics13050730
2.
ChanE.FoglerJ. M.HammernessP. G. (2016). Treatment of attention-deficit/hyperactivity disorder in adolescents: A systematic review. JAMA - Journal of the American Medical Association, 315(18), 1997–2008. https://doi.org/10.1001/jama.2016.5453
3.
ChenY.XiongW.ZhangY.BaiX.ChenG.ZhangY.ChenR.GuoY.KongH.ZhangY.QuH.ZhaoY. (2022). Carbon dots derived from os draconis and their anxiolytic effect. International Journal of Nanomedicine, 17, 4975–4988. https://doi.org/10.2147/IJN.S382112
4.
ChijanM. R.SalehiM.OstovarM.HaghjooE.RahimabadiM. S.HashempurM. H. (2022). The I-CAM-IR: Persian translation, cross-cultural adaptation and revised version of the I-CAM-Q. Traditional and Integrative Medicine, 7(4), 432–443. https://doi.org/10.18502/tim.v7i4.11494
5.
FaraoneS. V. (2018). The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience and Biobehavioral Reviews, 87, 255–270. https://doi.org/10.1016/j.neubiorev.2018.02.001
6.
FlemingM.FittonC. A.SteinerM. F. C.McLayJ. S.ClarkD.KingA.MackayD. F.PellJ. P. (2017). Educational and health outcomes of children treated for attention-deficit/hyperactivity disorder. JAMA Pediatrics, 171(7), e170691. https://doi.org/10.1001/jamapediatrics.2017.0691
7.
HajimonfarednejadM.OstovarM.HasheminasabF. S.ShariatiM. A.ThiruvengadamM.RaeeM. J.HashempurM. H. (2023). Medicinal plants for viral respiratory diseases: A systematic review on persian medicine. Evidence-Based Complementary and Alternative Medicine, 2023, Article 1928310. https://doi.org/10.1155/2023/1928310
8.
JiaJ.ChenJ.WangG.LiM.ZhengQ.LiD. (2023). Progress of research into the pharmacological effect and clinical application of the traditional Chinese medicine Rehmanniae Radix. Biomedicine and Pharmacotherapy, 168, Article 115809. https://doi.org/10.1016/j.biopha.2023.115809
9.
JunhuaZ.YoupingL.BoliZ.KejiC.QiW.ZhengjiL.SulunS.JinzhouT.XinS.ChenY.YanmingX.JingqingH.JinhuiT.SiyanZ.JianpingL.JingW.FengS.LiangD.JiajieY., . . . BoP. (2020). Evidence-based traditional Chinese medicine research: Beijing declaration. Chinese Journal of Evidence-Based Medicine, 20(8), 869–870. https://doi.org/10.7507/1672-2531.202003049
10.
LensingM. B.ZeinerP.SandvikL.OpjordsmoenS. (2015). Quality of life in adults aged 50+ with ADHD. Journal of Attention Disorders, 19(5), 405–413. https://doi.org/10.1177/1087054713480035
11.
LiuL.ZhouL.SunY. (2022). Bayesian network Meta-analysis of Chinese patent medicines in treatment of attention deficit hyperactivity disorder in children. Chinese Traditional and Herbal Drugs, 53(14), 4447–4464. https://doi.org/10.7501/j.issn.0253-2670.2022.14.024
12.
LiuM.WangX.GaoD. (2024). Polygalae Radix: Review of metabolites, pharmacological activities and toxicology. Frontiers in Pharmacology, 15, Article 1420853. https://doi.org/10.3389/fphar.2024.1420853
13.
MechlerK.BanaschewskiT.HohmannS.HägeA. (2022). Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology and Therapeutics, 230, Article 107940. https://doi.org/10.1016/j.pharmthera.2021.107940
14.
PadilhaS. C. O. S.VirtuosoS.ToninF. S.BorbaH. H. L.PontaroloR. (2018). Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: A network meta-analysis. European Child and Adolescent Psychiatry, 27(10), 1335–1345. https://doi.org/10.1007/s00787-018-1125-0
RenL.ZhaoL.ZhuP. (2021). Clinical study on Jingling oral liquid combined with atomoxetine hydrochloride for attention deficit hyperactivity disorder. Journal of New Chinese Medicine, 53(8), 93–95.
17.
SaiZ.YuanxiongD.ZijiaC.SumeiW. (2023). How does traditional chinese medicine treat attention deficit hyperactivity disorder-A different understanding and treatment strategy. Open Journal of Orthopedics and Rheumatology, 8(1), 13–17. https://doi.org/10.17352/ojor.000048
18.
SharmaA.CoutureJ. (2014). A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Annals of Pharmacotherapy, 48(2), 209–225. https://doi.org/10.1177/1060028013510699
19.
ShierA. C.ReichenbacherT.GhumanH. S.GhumanJ. K. (2013). Pharmacological treatment of Attention Deficit Hyperactivity Disorder in children and adolescents: Clinical strategies. Journal of Central Nervous System Disease, 5, JCNSD.S6691. https://doi.org/10.4137/jcnsd.s6691
20.
SnyderJ.BrownP. (2012). Complementary and alternative medicine in children: An analysis of the recent literature. Current Opinion in Pediatrics, 24(4), 539–546. https://doi.org/10.1097/MOP.0b013e328355a214
21.
SteinM. A.SarampoteC. S.WaldmanI. D.RobbA. S.ConlonC.PearlP. L.BlackD. O.SeymourK. E.NewcornJ. H. (2003). A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics, 112(5), e404. https://doi.org/10.1542/peds.112.5.e404
22.
StorebøO. J.RamstadE.KroghH. B.NilausenT. D.SkoogM.HolmskovM.RosendalS.GrothC.MagnussonF. L.Moreira-MaiaC. R.GilliesD.Buch RasmussenK.GauciD.ZwiM.KirubakaranR.ForsbølB.SimonsenE.GluudC. (2015). Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews, 2015(11), CD009885. https://doi.org/10.1002/14651858.CD009885.pub2
VinaE. R.YoukA. O.QuinonesC.KwohC. K.IbrahimS. A.HausmannL. R. M. (2021). Use of complementary and alternative therapy for knee osteoarthritis: Race and gender variations. ACR Open Rheumatology, 3(9), 660–667. https://doi.org/10.1002/acr2.11307
25.
WangF.WenF.YuL.YanJ.LiuJ.LiY.CuiY. (2021). The efficacy and safety in attention deficit hyperactivity disorder of second-generation antipsychotics and other medications for hyperactivity in children and adolescents with autism: A meta-analysis. International Clinical Psychopharmacology, 36(3), 109–116. https://doi.org/10.1097/YIC.0000000000000349
26.
WangG.ZhaoH.LiQ.WangS.KongY.QuY. (2020). Effect of methylphenidate hydrochloride controlled release tablets combined with jingling oral liquid in the treatment of children with ADHD. Minerva Medica. Advance online publication. https://doi.org/10.23736/s0026-4806.20.07103-7
27.
WangH.DaiJ. Y.HeY. Z.XiaZ. W.ChenX. F.HongZ. Y.ChaiY. F. (2022). Therapeutic effect and mechanism of Anemarrhenae Rhizoma on Alzheimer’s disease based on multi-platform metabolomics analyses. Frontiers in Pharmacology, 13, Article 940555. https://doi.org/10.3389/fphar.2022.940555
28.
WenJ.YangY.HaoJ. (2023). Acori Tatarinowii Rhizoma: A comprehensive review of its chemical composition, pharmacology, pharmacokinetics and toxicity. Frontiers in Pharmacology, 14, Article 1090526. https://doi.org/10.3389/fphar.2023.1090526
29.
WillcuttE. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9(3), 490–499. https://doi.org/10.1007/s13311-012-0135-8
30.
WooB. S. C.ReyJ. M. (2005). The validity of the DSM-IV subtypes of Attention-Deficit/Hyperactivity Disorder. Australian & New Zealand Journal of Psychiatry, 39(5), 344–353. https://doi.org/10.1080/j.1440-1614.2005.01580.x
31.
WuJ.LiP.LuoH.LuY. (2022). Complementary and alternative medicine use by ADHD patients: A systematic review. Journal of Attention Disorders, 26(14), 1833–1845. https://doi.org/10.1177/10870547221111557
32.
XuL.TengY. (2020). Therapeutic effect of Jingling oral Liquidcombined with central nervous stimulant on ADHD in children. Chinese Journal of Woman and Child Health Research, 31(10), 1388–1392.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
